KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non-cash Items (2017 - 2018)

Teva Pharmaceutical Industries (TEVA) has disclosed Non-cash Items for 8 consecutive years, with $2.4 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Non-cash Items changed N/A year-over-year to $2.4 million, compared with a TTM value of $2.4 million through Dec 2018, changed N/A, and an annual FY2018 reading of $2.4 million, changed N/A over the prior year.
  • Non-cash Items was $2.4 million for Q4 2018 at Teva Pharmaceutical Industries, down from $14.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $402.4 million in Q4 2015 and bottomed at $2.4 million in Q4 2018.
  • Average Non-cash Items over 4 years is $108.0 million, with a median of $13.6 million recorded in 2014.
  • The sharpest move saw Non-cash Items skyrocketed 3085.72% in 2015, then tumbled 96.4% in 2016.
  • Year by year, Non-cash Items stood at $12.6 million in 2014, then surged by 3085.72% to $402.4 million in 2015, then crashed by 96.4% to $14.5 million in 2016, then plummeted by 83.41% to $2.4 million in 2018.
  • Business Quant data shows Non-cash Items for TEVA at $2.4 million in Q4 2018, $14.5 million in Q4 2016, and $402.4 million in Q4 2015.